Digitalis bei Herzinsuffizienz - Prof. Dr. Udo Bavendiek (Hannover)

Professor Dr. Udo Bavendiek explains the significance of digitalis in the treatment of heart failure with reduced ejection fraction, focusing on his DIGIT-HF study, which was presented as a late-breaking study at the 2025 Annual Congress of the European Society of Cardiology and published in the New England Journal of Medicine. Professor Dr. Bavendiek is a cardiologist at Hannover Medical School (MHH) and first author of the DIGIT-HF study. The interview was conducted on February 23, 2026. Moderators: Professor Dr. Florian Custodis (Saarbrücken), Professor Dr. Dr. Stephan Schirmer (Kaiserslautern), Professor Dr. Gunnar Heine (Frankfurt am Main). Further reading: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. Bavendiek U, Großhennig A, Schwab J, Berliner D, Rieth A, Maier LS, Gaspar T, Thomas NH, Liu X, Schallhorn S, Angelini E, Soltani S, Rathje F, Sandu MA, Geller W, Hambrecht R, Zdravkovic M, Philipp S, Kosevic D, Nickenig G, Scheiber D, Winkler S, Becher PM, Lurz P, Hülsmann M, Wiesner S, Schröder C, Neuhaus B, Seltmann A, von der Leyen H, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J; DIGIT-HF Study Group N Engl J Med 2025 doi: 10.1056/NEJMoa2415471